Featured

Recent Posts

An Introduction to MedDRA Coding: Structuring Clinical Terminology in Drug Safety & CDM

Introduction When a patient or physician reports an adverse event during a clinical trial or post-marketing surveillance, they...

What is a Medical Device Incident? An Introduction to Materiovigilance Reporting

Introduction While Pharmacovigilance (PV) monitors adverse reactions to pharmaceutical molecules, Materiovigilance (MV) is dedicated to monitoring the safety...

The Core Lifecycle of a Clinical Trial: From Protocol Phase 1 to Phase 4 Operations

Introduction Developing a new pharmaceutical molecule and bringing it safely to market is a rigorous, multi-year process governed...

Bridging the Gap: What Pharmacy & Life Science Curricula Miss About Industry PV

Introduction Academic programs in pharmacy (B.Pharm/M.Pharm) and life sciences provide a strong foundational understanding of pharmacology, chemistry, and...

Architecting Truth in Clinical Research: The End-to-End Clinical Data Management Process

Every medical breakthrough—whether a novel gene therapy, a targeted oncology drug, or a newly developed vaccine—relies completely on...

Mastering Materiovigilance: The Definitive Guide to Post-Market Safety Monitoring for Medical Devices

The modern healthcare ecosystem relies heavily on an intricate network of biomedical engineering marvels. From simple diagnostic tools...

Drug Safety Beyond Approval: Why Post-Marketing Surveillance Matters

A medicine may appear safe during clinical trials, but its complete safety profile is often revealed only after...